ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

The task of developing CPG documents covers not only integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

SciELO - Brasil - Diretriz Brasileira de Cardio-oncologia – 2020 Diretriz Brasileira de Cardio-oncologia
– 2020 Acessibilidade / Reportar erro Brasil Lista alfabética de periódicos Lista temática de …

This position statement from the Heart Failure Association of the European Society of
Cardiology Cardio‐Oncology Study Group in collaboration with the International Cardio …

Aims Anticancer therapies have extended the lives of millions of patients with malignancies,
but for some this benefit is tempered by adverse cardiovascular (CV) effects. Cardiotoxicity …

The considerable progress made in the field of cancer treatment has led to a dramatic
improvement in the prognosis of patients with cancer. However, toxicities resulting from …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Though not defined in detail, this discipline sees itself at the intersection of
oncology/haematology and cardiology, with a particular focus on mitigating and managing …

Cancer and cardiovascular (CV) disease are the most prevalent diseases in the developed
world. Evidence increasingly shows that these conditions are interlinked through common …

The task of developing ESC/EACTS Guidelines covers not only the integration of the most
recent research, but also the creation of educational tools and implementation programmes …